Physician profile
Lori A Platt
NPI 1598923484
$14,470.21
in general payments reported to CMS, 2019-2025
25 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $27.12 · 2021: $13K · 2022: $113 · 2023: $381 · 2024: $498 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $987 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $987.33 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,029.66 | 2021-2024 | |
| Abbvie INC. | $227.73 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $212.81 | 2024 | Xifaxan |
| Astellas Pharma US INC | $159.28 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $103.30 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $98.61 | 2023 | Myrisk |
| Organon LLC | $94.08 | 2022-2024 | |
| Octapharma USA, INC. | $55.94 | 2025 | Fibryga |
| Conmed Corporation | $51.24 | 2024 | Airseal |
| Sumitomo Pharma America, INC. | $46.22 | 2024-2025 | Myfembree |
| Coopersurgical, INC. | $45.35 | 2022-2023 | Paragard T 380a |
| Covidien LP | $38.32 | 2019 | |
| Medtronic, INC. | $36.63 | 2023 | Ligasure |
| Channel Medsystems, INC. | $34.60 | 2023-2024 | |
| Mayne Pharma Commercial LLC | $34.09 | 2022-2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $33.29 | 2023-2024 | Spinraza |
| Pfizer INC. | $25.85 | 2019-2022 | |
| Amgen INC. | $25.32 | 2019-2025 | Evenity, Prolia |
| Therapeuticsmd, INC. | $22.00 | 2019-2020 | |
| Emd Serono, INC. | $19.98 | 2019 | |
| Medicem INC. | $18.96 | 2021 | |
| Heron Therapeutics, INC. | $16.65 | 2025 | Zynrelef |
| Novo Nordisk INC | $14.56 | 2023 | Wegovy |
| Merck Sharp & Dohme LLC | $14.39 | 2022 | |
| Allergan, INC. | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Platt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.